Ashwin Somasundaram

1.6k total citations · 1 hit paper
33 papers, 804 citations indexed

About

Ashwin Somasundaram is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Ashwin Somasundaram has authored 33 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Immunology. Recurrent topics in Ashwin Somasundaram's work include Cancer Immunotherapy and Biomarkers (15 papers), Immune Cell Function and Interaction (7 papers) and Lung Cancer Treatments and Mutations (7 papers). Ashwin Somasundaram is often cited by papers focused on Cancer Immunotherapy and Biomarkers (15 papers), Immune Cell Function and Interaction (7 papers) and Lung Cancer Treatments and Mutations (7 papers). Ashwin Somasundaram collaborates with scholars based in United States, Japan and India. Ashwin Somasundaram's co-authors include Timothy F. Burns, Laura P. Stabile, Tullia C. Bruno, Creg J. Workman, Dario A.A. Vignali, Feng Shan, Evan J. Lipson, Daniel P. Normolle, Robert L. Ferris and Mark A. Socinski and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Ashwin Somasundaram

29 papers receiving 799 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Therapeutic targeting of regulatory T cells in cancer

2022 143 citations Ashwin Somasundaram, Tullia C. Bruno et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ashwin Somasundaram United States	12	397	304	291	146	121	33	804
Iris de Rink Netherlands	11	348 0.9×	478 1.6×	305 1.0×	77 0.5×	161 1.3×	19	882
Andrew N. Stephens Australia	17	342 0.9×	304 1.0×	221 0.8×	81 0.6×	162 1.3×	32	892
Leila R. Martins Portugal	14	312 0.8×	652 2.1×	255 0.9×	93 0.6×	130 1.1×	21	1.1k
Qingyang Lei China	8	441 1.1×	333 1.1×	392 1.3×	143 1.0×	225 1.9×	15	852
Brian Riesenberg United States	13	356 0.9×	317 1.0×	321 1.1×	85 0.6×	125 1.0×	17	857
Anne Paulien Drenth Netherlands	10	431 1.1×	482 1.6×	197 0.7×	86 0.6×	185 1.5×	13	838
Jay Overholser United States	11	358 0.9×	439 1.4×	186 0.6×	117 0.8×	157 1.3×	16	767
Nina G. Steele United States	13	472 1.2×	276 0.9×	220 0.8×	114 0.8×	176 1.5×	28	811
Remi Adelaiye‐Ogala United States	14	356 0.9×	563 1.9×	318 1.1×	312 2.1×	193 1.6×	26	1.0k

Countries citing papers authored by Ashwin Somasundaram

Since Specialization

Citations

This map shows the geographic impact of Ashwin Somasundaram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashwin Somasundaram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashwin Somasundaram more than expected).

Fields of papers citing papers by Ashwin Somasundaram

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashwin Somasundaram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashwin Somasundaram. The network helps show where Ashwin Somasundaram may publish in the future.

Co-authorship network of co-authors of Ashwin Somasundaram

This figure shows the co-authorship network connecting the top 25 collaborators of Ashwin Somasundaram. A scholar is included among the top collaborators of Ashwin Somasundaram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashwin Somasundaram. Ashwin Somasundaram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ruffin, Ayana T., Sheryl Kunning, Anjali Rohatgi, et al.. (2025). Dysfunctional CD11c ⁻ CD21 ⁻ extrafollicular memory B cells are enriched in the periphery and tumors of patients with cancer. Science Translational Medicine. 17(786). eadh1315–eadh1315. 4 indexed citations

Somasundaram, Ashwin, Dominic T. Moore, Anita Turk, et al.. (2025). Phase II Study of Ipilimumab, Nivolumab, and Panitumumab in Patients With KRAS / NRAS / BRAF Wild-Type Microsatellite Stable Metastatic Colorectal Cancer. 1 indexed citations

Drizyte‐Miller, Kristina, et al.. (2025). KRAS: the Achilles’ heel of pancreas cancer biology. Journal of Clinical Investigation. 135(16). 4 indexed citations

Yu, Shawn, Menggang Yu, David Mauro, et al.. (2024). A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma. The Oncologist. 29(3). 270–e413. 20 indexed citations

Wang, Hong, Terry Evans, James G. Herman, et al.. (2024). Brief Report: Phase II Clinical Trial of Atezolizumab in Advanced Nonsmall Cell Lung Cancer Patients Previously Treated With PD-1-Directed Therapy. Clinical Lung Cancer. 26(1). 78–81. 1 indexed citations

Pimiento, José M., Diane Riccardi, Allan Andresson Lima Pereira, et al.. (2024). Feasibility trial of STRONG: A digital intervention to improve nutritional management for individuals with esophageal and gastroesophageal junction cancer. Contemporary Clinical Trials Communications. 43. 101421–101421.

Somasundaram, Ashwin, Anthony R. Cillo, Caleb Lampenfeld, et al.. (2022). Systemic Immune Dysfunction in Cancer Patients Driven by IL6 Induction of LAG3 in Peripheral CD8+ T Cells. Cancer Immunology Research. 10(7). 885–899. 18 indexed citations

Rahman, Syed A., Anthony R. Cillo, Ashwin Somasundaram, et al.. (2022). Antibodies targeting conserved non-canonical antigens and endemic coronaviruses associate with favorable outcomes in severe COVID-19. Cell Reports. 39(13). 111020–111020. 12 indexed citations

Thangaraj, Jeromie Wesley Vivian, et al.. (2022). Clinical profile of patients infected with suspected SARS-CoV-2 Omicron variant of concern, Tamil Nadu, India, December 2021-January 2022. The Indian Journal of Medical Research. 155(1). 165–170. 10 indexed citations

10.

Jones, Britta E., Henry T. Bahnson, Ashwin Somasundaram, et al.. (2022). Fewer LAG-3+ T Cells in Relapsing-Remitting Multiple Sclerosis and Type 1 Diabetes. The Journal of Immunology. 208(3). 594–602. 25 indexed citations

11.

Ma, Xiaojun, Ashwin Somasundaram, Zengbiao Qi, et al.. (2021). SPaRTAN, a computational framework for linking cell-surface receptors to transcriptional regulators. Nucleic Acids Research. 49(17). 9633–9647. 6 indexed citations

12.

Andrews, Lawrence P., Ashwin Somasundaram, Jessica Moskovitz, et al.. (2020). Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 shedding. Science Immunology. 5(49). 59 indexed citations

13.

Somasundaram, Ashwin, et al.. (2020). Immune Checkpoint Blockade in Oncogene-Driven Non-Small-Cell Lung Cancer. Drugs. 80(9). 883–892. 8 indexed citations

14.

Liu, Chang, Ashwin Somasundaram, Sasikanth Manne, et al.. (2020). Neuropilin-1 is a T cell memory checkpoint limiting long-term antitumor immunity. Nature Immunology. 21(9). 1010–1021. 101 indexed citations

15.

Somasundaram, Ashwin, et al.. (2018). The Role of the Estrogen Pathway in the Tumor Microenvironment. International Journal of Molecular Sciences. 19(2). 611–611. 142 indexed citations

16.

Yochum, Zachary A., Jessica Cades, Lucia Mazzacurati, et al.. (2017). A First-in-Class TWIST1 Inhibitor with Activity in Oncogene-Driven Lung Cancer. Molecular Cancer Research. 15(12). 1764–1776. 69 indexed citations

17.

Somasundaram, Ashwin & Timothy F. Burns. (2017). Pembrolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives. PubMed. Volume 8. 1–11. 11 indexed citations

18.

Somasundaram, Ashwin & Timothy F. Burns. (2017). The next generation of immunotherapy: keeping lung cancer in check. Journal of Hematology & Oncology. 10(1). 87–87. 83 indexed citations

19.

Rajasekaran, A., et al.. (2010). Synthesis and evaluation of anti-microbial and analgesic activity of some (4Z)- 3-methyl-1-[(2-oxo-2H-chromen-4-yl) carbonyl]-1H-pyrazole-4, 5-dione 4-[(4- substitutedphenyl) hydrazone]. Der pharmacia lettre. 2(1). 211–219. 4 indexed citations

20.

Somasundaram, Ashwin, et al.. (2009). Antimicrobial activity of Cassia roxburghii seeds in vitro.. 2(1). 15–19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact